StackItSmart

Compound reference

T4

Levothyroxine · Synthroid

Other compounds1 cited findingClinical review: not reviewed

Safety findings

Regulatory recordSupporting passage inspected

SYNTHROID carries a boxed warning against use for obesity or weight loss. Excess thyroid-hormone exposure can produce serious or life-threatening toxicity, particularly with sympathomimetic agents.[1]

  • This warning does not mean appropriate thyroid replacement is equivalent to excessive exposure.
Inspection history

Clinical review: not reviewed by a qualified clinician.

· Independent source inspection; applicability narrowed and inherited assertions excluded where unsupported. No qualified clinical review.

· Independently reopened the current DailyMed label (SPL version 1537, Effective Time 2024-02-20, confirmed the latest of 24 indexed versions). Confirmed the boxed warning verbatim (identical wording to CYTOMEL's, substituting SYNTHROID) and section 7.7 (Sympathomimetics). Same section 5.1-versus-5 precision note as the CYTOMEL claim. No qualified clinical review.

What remains unresolved

Editorial assessment

These notes describe the scope of this review. Linked PMIDs are audit identifiers; an identifier alone does not verify a claim.

Narrowly supported passages published with study/product limits; remaining inherited assertions withheld from established-fact displays.

  • Not a comprehensive systematic review. Original monograph topics beyond the individual published claims—including monitoring schedules, contraindication lists, recovery assurances and detailed mechanisms—remain unverified.
  • No qualified clinician has reviewed these claims. Long-term outcomes and all marketed formulations have not been fully assessed.

This reference does not supply a dosing plan, monitoring timetable or recovery regimen. Discuss personal symptoms, medicines and laboratory results with a qualified clinician.

Explore the interaction evidence for this compound →

References

  1. SYNTHROID levothyroxine: prescribing information

    2024-02-20. Product label.

    Inspected location: Boxed warning; sections 1, 5.2 and 7.7

    Study context and inspection record

Source inspection and clinical review are separate. An abstract check is not a full-text review. The records above identify what was actually inspected and do not certify the complete literature.

Recorded verification attempts
  • Fresh PubMed EUtils retrieval for inherited lead PMID 25266247; identity, abstract and linked corrections checked where an abstract existed.
  • https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc — label; Boxed warning; sections 1, 5 and 7.7

View this compound in the research library →

Related records in this class

Grouped under Other compounds for navigation only. Shared class membership does not make findings, formulations or evidence interchangeable between records.

StackItSmart

Age confirmation

This reference discusses steroids, SARMs and other compounds. It is educational, not medical advice, and does not recommend using or combining them.

Your confirmation is saved in this browser when storage is available.